Kaken Pharmaceutical Co., Ltd. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Kaken Pharmaceutical Co., Ltd. (KKPCF) is 96.83B

According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 96.83B. This represents a change of -8.61% compared to the average of 105.95B of the last 4 quarters.

Kaken Pharmaceutical Co., Ltd. (KKPCF) Historical Enterprise Value (quarterly & annually)

How has KKPCF Enterprise Value performed in the past?

The mean historical Enterprise Value of Kaken Pharmaceutical Co., Ltd. over the last ten years is 134.55B. The current 96.83B Enterprise Value has changed 7.10% with respect to the historical average. Over the past ten years (40 quarters), KKPCF's Enterprise Value was at its highest in in the December 2016 quarter at 232.39B. The Enterprise Value was at its lowest in in the December 2023 quarter at 79.45B.

Kaken Pharmaceutical Co., Ltd. (KKPCF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kaken Pharmaceutical Co., Ltd. (KKPCF) Average Enterprise Value

How has KKPCF Enterprise Value performed in the past?

The current Enterprise Value of Kaken Pharmaceutical Co., Ltd. (KKPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kaken Pharmaceutical Co., Ltd. (KKPCF) Enterprise Value vs. Peers

How is KKPCF’s Enterprise Value compared to its peers?

Kaken Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Amphastar Pharmaceuticals, Inc. (1.51B), greater than Aquestive Therapeutics, Inc. (535.78M), greater than BioGaia AB (publ) (10.46B), less than Swedish Orphan Biovitrum AB (publ) (172.23B), greater than Genomma Lab Internacional, S.A.B. de C.V. (17.51B), greater than Hikma Pharmaceuticals PLC (6.17B), less than Kissei Pharmaceutical Co., Ltd. (137.10B),

Build a custom stock screener for Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.